Conclusion
Patients with AIA have limited alternatives for use of medications in inflammatory processes. There is no evidence of immunologic cross-reactivity as the cause of AIA, but instead evidence implicates inhibition of COX as the initiating event. Successful use of COX-2 inhibitors in AIA patients also suggests that inhibition of COX-1 and the subsequent decrease in prostaglandins and increase in leukotrienes are likely causes. Cyclooxygenase-2 inhibitors, despite contraindications in the package information of their manufacturers, may be safe alternatives for AIA patients who require anti-inflammatory medications.
Reprint requests to Kristopher Harrell, PharmD, University of Mississippi Medical Center, Department of Clinical Pharmacy Practice, 2500 N. State St. Jackson, MS 39216.
South Med J. 2001;94(2) © 2001 Lippincott Williams & Wilkins
Cite this: Successful Use of Cyclooxygenase-2 Inhibitor in a Patient With Aspirin-Induced Asthma - Medscape - Feb 01, 2001.
Comments